Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case‐control study-Reference-Cited by-同舟云学术

Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case‐control study

Published:2020-10-28 Issue:11 Volume:40 Page:2848-2857
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Xiong Jianping¹^ORCID,Wang Yaqin²,Xu Weiyu³,Liu Zhisong⁴,Wang Haochen¹,Zhang Zhiyuan¹,Han Yanjing¹,Yin Chao¹,Cao Shasha¹,Yang Zheran¹,Su Tianhao¹,Wei Jian¹,Chen Guang¹,Jin Long¹

Affiliation:

1. Department of Interventional Radiology Beijing Friendship HospitalCapital Medical University Beijing China

2. Department of Interventional Radiology The First Affiliated Hospital of China Medical University Shenyang China

3. Department of General Surgery Beijing Friendship HospitalCapital Medical University Beijing China

4. Faculty of Statistics Tianjin University of Finance and Economics Tianjin China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14663

Reference43 articles.

1. Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study

2. Peptic ulcer disease

3. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

4. Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data

5. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Nomogram for Diagnosing Malignant Biliary Strictures: A Retrospective Study;2024-04-01

2. Association between proton pump inhibitor use and the risk of hepatobiliary cancers: A meta‐analysis;Advances in Digestive Medicine;2024-02

3. Digestive Tract Cancer-Related Adverse Events Correlated with Proton Pump Inhibitors Use: A Pharmacovigilance Study of the FDA Adverse Event Reporting System;Journal of Clinical Pharmacy and Therapeutics;2023-10-13

4. Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts;International Journal of Cancer;2023-05-26

5. Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis;Frontiers in Pharmacology;2022-09-14